Experiment 112912

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

JANTHINOCIN B

Alerts

A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
OrganismJanthinobacterium lividum (TO BE DETERMINED)
CitationO'SULLIVAN,J: MC CULLOUGH,J: JOHNSON,JH: BONNER,DP: CLARK,JC: DEAN,L: TREJO,WH:. (1990). JANTHINOCINS A, B AND C, NOVEL PEPTIDE LACTONE ANTIBIOTICS PRODUCED BY JANTHINOBACTERIUM LIVIDUM. I. TAXONOMY, FERMENTATION, ISOLATION, PHYSICO-CHEMICAL AND BIOLOGICAL CHARACTERIZATION.. 43(8)
Amount utilized
Compound isolated
DiseaseMIXTURE OF JANTHINOMICINS A AND B.
Dose amount50.0 MCG
Number93
Qualitative resultWEAK ACTIVITY
AnimalAGAR PLATE
Per unitML
Dose expressionMIC